Table of Contents

company-logo

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

Northwest Biotherapeutics Dividend Announcement

• Northwest Biotherapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Northwest Biotherapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Northwest Biotherapeutics Dividend History

Northwest Biotherapeutics Dividend Yield

Northwest Biotherapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Northwest Biotherapeutics stock? Use our calculator to estimate your expected dividend yield:

Northwest Biotherapeutics Financial Ratios

P/E ratio-4.48
PEG ratio0.01
P/B ratio-5.19
ROE134.02%
Payout ratio-0.59%
Current ratio0.09
Quick ratio0.09
Cash Ratio0.05

Northwest Biotherapeutics Dividend FAQ

Does Northwest Biotherapeutics stock pay dividends?
Northwest Biotherapeutics does not currently pay dividends to its shareholders.
Has Northwest Biotherapeutics ever paid a dividend?
No, Northwest Biotherapeutics has no a history of paying dividends to its shareholders. Northwest Biotherapeutics is not known for its dividend payments.
Why doesn't Northwest Biotherapeutics pay dividends?
There are several potential reasons why Northwest Biotherapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Northwest Biotherapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Northwest Biotherapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Northwest Biotherapeutics a dividend aristocrat?
Northwest Biotherapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Northwest Biotherapeutics a dividend king?
Northwest Biotherapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Northwest Biotherapeutics a dividend stock?
No, Northwest Biotherapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Northwest Biotherapeutics stocks?
To buy Northwest Biotherapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Northwest Biotherapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.